The global liquid embolic agent market was valued at USD 243.90 million in 2024 and is expected to grow at a compound annual growth rate of 9.7 percent from 2025 to 2034. Backed by robust demand for less invasive vascular therapies and increasing prevalence of neurovascular and oncology-related vascular conditions, the market forecast is firmly data-anchored. In 2024, North America emerged as...
Italiano 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Russian
Romaian
Portuguese (Brazil)
Greek